These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25613678)

  • 21. Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor.
    Mosure KW; Knipe JO; Browning M; Arora V; Shu YZ; Phillip T; Mcphee F; Scola P; Balakrishnan A; Soars MG; Santone K; Sinz M
    J Pharm Sci; 2015 Sep; 104(9):2813-23. PubMed ID: 25631585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates.
    Cannalire R; Barreca ML; Manfroni G; Cecchetti V
    J Med Chem; 2016 Jan; 59(1):16-41. PubMed ID: 26241789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor.
    Lin TI; Lenz O; Fanning G; Verbinnen T; Delouvroy F; Scholliers A; Vermeiren K; Rosenquist A; Edlund M; Samuelsson B; Vrang L; de Kock H; Wigerinck P; Raboisson P; Simmen K
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1377-85. PubMed ID: 19171797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: further optimization of anti-hepatitis C virus activity.
    Puerstinger G; Paeshuyse J; Heinrich S; Mohr J; Schraffl N; De Clercq E; Neyts J
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5111-4. PubMed ID: 17656093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants.
    Kazmierski WM; Hamatake R; Duan M; Wright LL; Smith GK; Jarvest RL; Ji JJ; Cooper JP; Tallant MD; Crosby RM; Creech K; Wang A; Li X; Zhang S; Zhang YK; Liu Y; Ding CZ; Zhou Y; Plattner JJ; Baker SJ; Bu W; Liu L
    J Med Chem; 2012 Apr; 55(7):3021-6. PubMed ID: 22471376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061.
    Llinàs-Brunet M; Bailey MD; Bolger G; Brochu C; Faucher AM; Ferland JM; Garneau M; Ghiro E; Gorys V; Grand-Maître C; Halmos T; Lapeyre-Paquette N; Liard F; Poirier M; Rhéaume M; Tsantrizos YS; Lamarre D
    J Med Chem; 2004 Mar; 47(7):1605-8. PubMed ID: 15027850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing.
    Sun LQ; Mull E; Zheng B; D'Andrea S; Zhao Q; Wang AX; Sin N; Venables BL; Sit SY; Chen Y; Chen J; Cocuzza A; Bilder DM; Mathur A; Rampulla R; Chen BC; Palani T; Ganesan S; Arunachalam PN; Falk P; Levine S; Chen C; Friborg J; Yu F; Hernandez D; Sheaffer AK; Knipe JO; Han YH; Schartman R; Donoso M; Mosure K; Sinz MW; Zvyaga T; Rajamani R; Kish K; Tredup J; Klei HE; Gao Q; Ng A; Mueller L; Grasela DM; Adams S; Loy J; Levesque PC; Sun H; Shi H; Sun L; Warner W; Li D; Zhu J; Wang YK; Fang H; Cockett MI; Meanwell NA; McPhee F; Scola PM
    J Med Chem; 2016 Sep; 59(17):8042-60. PubMed ID: 27564532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Drug Discovery for Anti-hepatitis C Virus Targeting NS4B.
    Wang Z; Chen X; Wu C; Xu H; Liu H
    Curr Top Med Chem; 2016; 16(12):1362-71. PubMed ID: 26585935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease.
    Chen KX; Nair L; Vibulbhan B; Yang W; Arasappan A; Bogen SL; Venkatraman S; Bennett F; Pan W; Blackman ML; Padilla AI; Prongay A; Cheng KC; Tong X; Shih NY; Njoroge FG
    J Med Chem; 2009 Mar; 52(5):1370-9. PubMed ID: 19196021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappings.
    Chen KX; Vibulbhan B; Yang W; Nair LG; Tong X; Cheng KC; Njoroge FG
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1105-9. PubMed ID: 19168351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups.
    Li X; Liu Y; Zhang YK; Plattner JJ; Baker SJ; Bu W; Liu L; Zhou Y; Ding CZ; Zhang S; Kazmierski WM; Hamatake R; Duan M; Wright LL; Smith GK; Jarvest RL; Ji JJ; Cooper JP; Tallant MD; Crosby RM; Creech K; Wang A
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7351-6. PubMed ID: 23142614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase.
    Talamas FX; Abbot SC; Anand S; Brameld KA; Carter DS; Chen J; Davis D; de Vicente J; Fung AD; Gong L; Harris SF; Inbar P; Labadie SS; Lee EK; Lemoine R; Le Pogam S; Leveque V; Li J; McIntosh J; Nájera I; Park J; Railkar A; Rajyaguru S; Sangi M; Schoenfeld RC; Staben LR; Tan Y; Taygerly JP; Villaseñor AG; Weller PE
    J Med Chem; 2014 Mar; 57(5):1914-31. PubMed ID: 24195700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a novel class of potent HCV NS4B inhibitors: SAR studies on piperazinone derivatives.
    Kakarla R; Liu J; Naduthambi D; Chang W; Mosley RT; Bao D; Steuer HM; Keilman M; Bansal S; Lam AM; Seibel W; Neilson S; Furman PA; Sofia MJ
    J Med Chem; 2014 Mar; 57(5):2136-60. PubMed ID: 24476391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyridine hydroxamic acids are specific anti-HCV agents affecting HDAC6.
    Kozlov MV; Kleymenova AA; Romanova LI; Konduktorov KA; Kamarova KA; Smirnova OA; Prassolov VS; Kochetkov SN
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2382-5. PubMed ID: 25937017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Tedesco R; Shaw AN; Bambal R; Chai D; Concha NO; Darcy MG; Dhanak D; Fitch DM; Gates A; Gerhardt WG; Halegoua DL; Han C; Hofmann GA; Johnston VK; Kaura AC; Liu N; Keenan RM; Lin-Goerke J; Sarisky RT; Wiggall KJ; Zimmerman MN; Duffy KJ
    J Med Chem; 2006 Feb; 49(3):971-83. PubMed ID: 16451063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent and selective small molecule NS3 serine protease inhibitors of Hepatitis C virus with dichlorocyclopropylproline as P2 residue.
    Chen KX; Vibulbhan B; Yang W; Cheng KC; Liu R; Pichardo J; Butkiewicz N; Njoroge FG
    Bioorg Med Chem; 2008 Feb; 16(4):1874-83. PubMed ID: 18032054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A protease.
    Slater MJ; Amphlett EM; Andrews DM; Bamborough P; Carey SJ; Johnson MR; Jones PS; Mills G; Parry NR; Somers DO; Stewart AJ; Skarzynski T
    Org Lett; 2003 Nov; 5(24):4627-30. PubMed ID: 14627400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: from anti-pestivirus to anti-hepatitis C virus activity.
    Puerstinger G; Paeshuyse J; De Clercq E; Neyts J
    Bioorg Med Chem Lett; 2007 Jan; 17(2):390-3. PubMed ID: 17084081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease.
    Ding CZ; Zhang YK; Li X; Liu Y; Zhang S; Zhou Y; Plattner JJ; Baker SJ; Liu L; Duan M; Jarvest RL; Ji J; Kazmierski WM; Tallant MD; Wright LL; Smith GK; Crosby RM; Wang AA; Ni ZJ; Zou W; Wright J
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7317-22. PubMed ID: 21067923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.